In addition, IL-18 can be used as a biomarker to distinguish active adult-onset Still's disease (AOSD) from COVID-19; IL-18 is 68-fold higher in patients with active AOSD than in those with severe COVID-19. This evidence concerns the gene IL18 and COVID-19.